Healthcare provider profile · identity verified

Peter J Laureijs, M.D.

Family Practice · DE WITT, IA · NPI 1831141043

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Simvastatin	Simvastatin	569	131
Losartan Potassium	Losartan Potassium	554	132
Lisinopril	Lisinopril	521	104
Levothyroxine Sodium	Levothyroxine Sodium	517	81
Atorvastatin Calcium	Atorvastatin Calcium	459	88
Furosemide	Furosemide	372	81
Pantoprazole Sodium	Pantoprazole Sodium	351	78
Metoprolol Succinate	Metoprolol Succinate	332	73
Omeprazole	Omeprazole	307	65
Metformin Hcl	Metformin Hcl	304	61
Hydrochlorothiazide	Hydrochlorothiazide	287	67
Citalopram Hbr	Citalopram Hydrobromide	259	51
Eliquis	Apixaban	255	37
Amlodipine Besylate	Amlodipine Besylate	246	52
Gabapentin	Gabapentin	244	39
Allopurinol	Allopurinol	227	46
Metoprolol Tartrate	Metoprolol Tartrate	204	45
Meloxicam	Meloxicam	175	50
Rosuvastatin Calcium	Rosuvastatin Calcium	166	41
Potassium Chloride	Potassium Chloride	159	28
Albuterol Sulfate Hfa	Albuterol Sulfate	143	62
Clopidogrel	Clopidogrel Bisulfate	138	24
Sertraline Hcl	Sertraline Hcl	107	20
Prednisone	Prednisone	99	24
Xarelto	Rivaroxaban	99	15
Buspirone Hcl	Buspirone Hcl	98	28
Metformin Hcl Er	Metformin Hcl	98	23
Pravastatin Sodium	Pravastatin Sodium	94	21
Donepezil Hcl	Donepezil Hcl	91	16
Terazosin Hcl	Terazosin Hcl	91	23
Ropinirole Hcl	Ropinirole Hcl	90	16
Atenolol	Atenolol	89	22
Duloxetine Hcl	Duloxetine Hcl	89	14
Paroxetine Hcl	Paroxetine Hcl	88	15
Carvedilol	Carvedilol	87	13
Propranolol Hcl	Propranolol Hcl	86	18
Spironolactone	Spironolactone	86	19
Tramadol Hcl	Tramadol Hcl	85	16
Hydralazine Hcl	Hydralazine Hcl	82	20
Escitalopram Oxalate	Escitalopram Oxalate	81	14
Ezetimibe	Ezetimibe	80	16
Farxiga	Dapagliflozin Propanediol	80	suppressed
Azithromycin	Azithromycin	77	64
Alprazolam	Alprazolam	74	28
Jantoven	Warfarin Sodium	73	suppressed
Januvia	Sitagliptin Phosphate	72	suppressed
Trazodone Hcl	Trazodone Hcl	71	13
Warfarin Sodium	Warfarin Sodium	68	15
Celecoxib	Celecoxib	65	15
Glimepiride	Glimepiride	62	11
Fluoxetine Hcl	Fluoxetine Hcl	61	suppressed
Alendronate Sodium	Alendronate Sodium	60	13
Ozempic	Semaglutide	57	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	suppressed
Amoxicillin	Amoxicillin	54	43
Famotidine	Famotidine	54	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	11
Acetaminophen-Codeine	Acetaminophen With Codeine	50	suppressed
Memantine Hcl	Memantine Hcl	50	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	48	suppressed
Glipizide	Glipizide	48	14
Finasteride	Finasteride	45	11
Montelukast Sodium	Montelukast Sodium	45	13
Baclofen	Baclofen	44	suppressed
Enalapril Maleate	Enalapril Maleate	44	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	12
Ondansetron Hcl	Ondansetron Hcl	44	19
Jardiance	Empagliflozin	43	suppressed
Nifedipine Er	Nifedipine	42	suppressed
Rybelsus	Semaglutide	41	suppressed
Clonazepam	Clonazepam	40	suppressed
Myrbetriq	Mirabegron	40	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	16
Mupirocin	Mupirocin	38	23
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	37	suppressed
Ventolin Hfa	Albuterol Sulfate	33	12
Lorazepam	Lorazepam	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Diazepam	Diazepam	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Tresiba Flextouch U-200	Insulin Degludec	28	suppressed
Brilinta	Ticagrelor	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	20
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Risperidone	Risperidone	25	suppressed
Albuterol Sulfate	Albuterol Sulfate	24	suppressed
Loperamide	Loperamide Hcl	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Cephalexin	Cephalexin	23	21
Cholestyramine	Cholestyramine (With Sugar)	23	suppressed
Clotrimazole	Clotrimazole	23	19
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	11
Nystatin	Nystatin	21	11
Digoxin	Digoxin	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Prevalite	Cholestyramine	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Probenecid	Probenecid	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Nabumetone	Nabumetone	15	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	15	13
Admelog	Insulin Lispro	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Restasis	Cyclosporine	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Norethindrone Acetate	Norethindrone Acetate	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Ramipril	Ramipril	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error